Propiedad y actividad de insiders de Serina Therapeutics, Inc. (SER): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $2.16 |
| Capitalización | $32M |
| Bolsa | AMEX |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-07-22 | Simon Farrell | A-Award | 30,500 | $66K |
| 2026-07-22 | Simon Farrell | |||
| 2026-07-07 | Brannan Stephen K. | P-Purchase | 1,000 | $2K |
| 2026-06-17 | Venkatesan Jay | C-Conversion | 224,152 | $504K |
| 2026-06-17 | Venkatesan Jay | A-Award | 15,250 | $30K |
| 2026-05-22 | Venkatesan Jay | P-Purchase | 589 | $1K |
| 2026-06-17 | Venkatesan Jay | C-Conversion | 96,525 | $500K |
| 2026-06-17 | Bailey Gregory | C-Conversion | 6,666,667 | $15.0M |
| 2026-06-17 | Bailey Gregory | A-Award | 3,333,333 | $16.7M |
| 2026-06-17 | Bailey Gregory | C-Conversion | 1,770,805 | $4.0M |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $259000 | $7.4M | $6.7M | $2.4M | $527000 | $584000 | $645000 | $7.6M | $3.7M | $3.1M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $308000 | $107000 | $131000 | $363000 | $326000 | $25000 | $4000 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $688000 | $7.6M | $7.9M | $4.1M | $2.3M | $2.2M | $2.5M | $7.6M | $5.7M | $6.1M |
| Inmovilizado Material | $195000 | $129000 | $90000 | $1.1M | 0 | 0 | 0 | $1.3M | $1.0M | $842000 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | $2.2M | $1.6M | 0 | $738000 | 0 | 0 | 0 |
| Activos Totales | $3.2M | $9.6M | $10.7M | $7.4M | $3.9M | $3.2M | $3.2M | $9.0M | $6.7M | $7.0M |
| Cuentas por Pagar | $261000 | $75000 | $150000 | $420000 | $761000 | $193000 | $568000 | $580000 | $744000 | $1.9M |
| Deuda a Corto | 0 | 0 | 0 | $428000 | $2.4M | $7.1M | $7.6M | 0 | 0 | 0 |
| Pasivos Corrientes | $25.6M | $1.3M | $2.4M | $3.3M | $5.4M | $9.0M | $10.1M | $1.4M | $2.4M | $3.6M |
| Deuda a Largo | 0 | 0 | 0 | $1.5M | $3.9M | $6.1M | $10.5M | $3.0M | 0 | $196000 |
| Pasivos Totales | $25.6M | $1.3M | $2.4M | $4.8M | $9.3M | $15.0M | $20.6M | $41.3M | $6.2M | $7.0M |
| Reservas | -$60.0M | -$66.6M | -$74.1M | -$86.2M | -$97.1M | -$105.7M | -$116.2M | -$33.2M | -$44.3M | -$63.5M |
| Patrimonio Neto | -$23.4M | $7.3M | $7.4M | $2.2M | -$5.1M | -$11.8M | -$17.2M | -$32.3M | $641000 | -$37000 |
| Deuda Total | 0 | 0 | 0 | $2.0M | $6.3M | $13.2M | $18.1M | $3.4M | $268000 | $196000 |
| Deuda Neta | -$259000 | -$7.4M | -$6.7M | -$396000 | $5.8M | $12.6M | $17.5M | -$4.2M | -$3.4M | -$2.9M |
| Capital Circulante | -$24.9M | $6.3M | $5.4M | $757000 | -$3.1M | -$6.7M | -$7.6M | $6.2M | $3.3M | $2.5M |
Salud financiera
| Deuda / Patrimonio | 0.17 |
| Ratio corriente | 6.65 |
Rentabilidad
| Rentabilidad sobre capital | -222.42% |
| Rentabilidad sobre capital invertido | -116.37% |
| Rentabilidad sobre activos | -82.03% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: ALGS · BRNS · CVM · GNTA · GRCE · INMB · JUNS
Explorar sector: Healthcare · Biotechnology
Más secciones de SER: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones